Medinotec (MDNC) Change in Accured Expenses (2022 - 2023)
Medinotec (MDNC) posted Change in Accured Expenses of $7797.0 for Q4 2023, down 2.17% on a QoQ basis from $7970.0 in Q3 2023, and down 44.14% year-over-year from $13957.0 in Q4 2022.
Medinotec (MDNC) Change in Accured Expenses (2022 - 2023) Analysis & Trends
Medinotec's Change in Accured Expenses history runs 2 years deep, the most recent figure standing at $7797.0 for Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2023 | 7,797.00 |
| Nov 30, 2023 | 7,797.00 |
| Aug 31, 2023 | 7,970.00 |
| Aug 31, 2023 | 7,970.00 |
| Nov 30, 2022 | 13,957.00 |
| Nov 30, 2022 | 13,957.00 |
| Aug 31, 2022 | 8,800.00 |
| Aug 31, 2022 | 8,800.00 |